Pelthos Therapeutics Inc. (PTHS) KPIs and segments
Close on Nov 17, 2026Market cap $26.19MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Pelthos Therapeutics's business
Pelthos Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
Commercial operations($M) | 15.4 | 10.7 | 0 | 0 | ||||
Research and Development operations($M) | 0.18 | 0.24 | 0 | 0 | ||||
Net product revenues($M) | 15.4 | 10.7 | 9.09 | 7.11 | 0 | 0 | ||
License and collaboration revenues($M) | 0.18 | 0.24 | 0 | 0 | ||||
Commercial operations($M) | 11.8 | 0 | ||||||
Research and Development operations($M) | 0.18 | 0 | ||||||
Research and Development operations($M) | -0.42 | 0.06 | -3.45 | -1.97 | ||||
Commercial operations($M) | -23 | -25.1 | 0 | 0 | ||||
Commercial operations($M) | 137 | 144 | 129 | 0 | ||||
Research and Development operations($M) | 0.41 | 1.10 | 1.11 | 1.37 | ||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?